nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLC22A1—prostate cancer	0.12	0.37	CbGaD
Indinavir—CYP3A5—prostate cancer	0.097	0.298	CbGaD
Indinavir—CYP2C19—prostate cancer	0.066	0.203	CbGaD
Indinavir—CYP3A4—prostate cancer	0.042	0.129	CbGaD
Indinavir—ABCC1—Abiraterone—prostate cancer	0.029	0.0623	CbGbCtD
Indinavir—SLCO1A2—Estrone—prostate cancer	0.0187	0.0402	CbGbCtD
Indinavir—SLCO1B1—Cabazitaxel—prostate cancer	0.0181	0.0388	CbGbCtD
Indinavir—SLCO1B1—Estrone—prostate cancer	0.0177	0.0379	CbGbCtD
Indinavir—ABCC2—Ethinyl Estradiol—prostate cancer	0.0138	0.0297	CbGbCtD
Indinavir—ABCC1—Conjugated Estrogens—prostate cancer	0.0137	0.0295	CbGbCtD
Indinavir—ABCC1—Mitoxantrone—prostate cancer	0.0125	0.0268	CbGbCtD
Indinavir—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0123	0.0263	CbGbCtD
Indinavir—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0116	0.0248	CbGbCtD
Indinavir—SLCO1A2—Estradiol—prostate cancer	0.0108	0.0231	CbGbCtD
Indinavir—CYP3A5—Flutamide—prostate cancer	0.0108	0.0231	CbGbCtD
Indinavir—CYP2C19—Nilutamide—prostate cancer	0.0105	0.0225	CbGbCtD
Indinavir—CYP2C19—Bicalutamide—prostate cancer	0.0105	0.0225	CbGbCtD
Indinavir—ABCC2—Conjugated Estrogens—prostate cancer	0.0102	0.0218	CbGbCtD
Indinavir—SLCO1B1—Estradiol—prostate cancer	0.0101	0.0218	CbGbCtD
Indinavir—ABCC1—Epirubicin—prostate cancer	0.0101	0.0217	CbGbCtD
Indinavir—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00964	0.0207	CbGbCtD
Indinavir—SLC22A1—Estradiol—prostate cancer	0.00949	0.0204	CbGbCtD
Indinavir—SLCO1A2—Prednisone—prostate cancer	0.00925	0.0199	CbGbCtD
Indinavir—CYP2C9—Nilutamide—prostate cancer	0.0087	0.0187	CbGbCtD
Indinavir—CYP2C9—Bicalutamide—prostate cancer	0.0087	0.0187	CbGbCtD
Indinavir—CYP2C19—Flutamide—prostate cancer	0.00868	0.0186	CbGbCtD
Indinavir—CYP2D6—Bicalutamide—prostate cancer	0.00796	0.0171	CbGbCtD
Indinavir—CYP3A5—Cabazitaxel—prostate cancer	0.00796	0.0171	CbGbCtD
Indinavir—ABCC1—Etoposide—prostate cancer	0.00787	0.0169	CbGbCtD
Indinavir—ABCB1—Estramustine—prostate cancer	0.00785	0.0169	CbGbCtD
Indinavir—CYP3A5—Estrone—prostate cancer	0.00778	0.0167	CbGbCtD
Indinavir—ABCC1—Docetaxel—prostate cancer	0.0072	0.0154	CbGbCtD
Indinavir—CYP2D6—Abiraterone—prostate cancer	0.0066	0.0142	CbGbCtD
Indinavir—CYP3A7—Estradiol—prostate cancer	0.00595	0.0128	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00595	0.0128	CbGbCtD
Indinavir—ABCC2—Etoposide—prostate cancer	0.00582	0.0125	CbGbCtD
Indinavir—ABCC1—Doxorubicin—prostate cancer	0.00536	0.0115	CbGbCtD
Indinavir—ABCC2—Docetaxel—prostate cancer	0.00533	0.0114	CbGbCtD
Indinavir—CYP2C9—Estrone—prostate cancer	0.00521	0.0112	CbGbCtD
Indinavir—ABCB1—Cabazitaxel—prostate cancer	0.00518	0.0111	CbGbCtD
Indinavir—CYP3A4—Bicalutamide—prostate cancer	0.00506	0.0109	CbGbCtD
Indinavir—ABCB1—Estrone—prostate cancer	0.00506	0.0109	CbGbCtD
Indinavir—CYP3A4—Estramustine—prostate cancer	0.00471	0.0101	CbGbCtD
Indinavir—ABCB1—Ethinyl Estradiol—prostate cancer	0.00451	0.00968	CbGbCtD
Indinavir—CYP3A5—Estradiol—prostate cancer	0.00447	0.00959	CbGbCtD
Indinavir—CYP3A4—Abiraterone—prostate cancer	0.00419	0.009	CbGbCtD
Indinavir—CYP3A4—Flutamide—prostate cancer	0.00419	0.009	CbGbCtD
Indinavir—ABCC2—Doxorubicin—prostate cancer	0.00397	0.00852	CbGbCtD
Indinavir—CYP2C9—Capecitabine—prostate cancer	0.00395	0.00848	CbGbCtD
Indinavir—CYP2C19—Estradiol—prostate cancer	0.0036	0.00773	CbGbCtD
Indinavir—CYP3A7—Docetaxel—prostate cancer	0.00356	0.00763	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00356	0.00763	CbGbCtD
Indinavir—ABCB1—Conjugated Estrogens—prostate cancer	0.00331	0.00711	CbGbCtD
Indinavir—CYP3A4—Cabazitaxel—prostate cancer	0.0031	0.00666	CbGbCtD
Indinavir—CYP2C19—Prednisone—prostate cancer	0.0031	0.00665	CbGbCtD
Indinavir—CYP3A4—Estrone—prostate cancer	0.00303	0.00651	CbGbCtD
Indinavir—ABCB1—Mitoxantrone—prostate cancer	0.00301	0.00646	CbGbCtD
Indinavir—CYP2C9—Estradiol—prostate cancer	0.003	0.00643	CbGbCtD
Indinavir—CYP3A5—Etoposide—prostate cancer	0.00292	0.00626	CbGbCtD
Indinavir—ABCB1—Estradiol—prostate cancer	0.00291	0.00624	CbGbCtD
Indinavir—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0027	0.0058	CbGbCtD
Indinavir—CYP3A5—Docetaxel—prostate cancer	0.00267	0.00573	CbGbCtD
Indinavir—ABCB1—Prednisone—prostate cancer	0.0025	0.00537	CbGbCtD
Indinavir—CYP3A4—Conjugated Estrogens—prostate cancer	0.00198	0.00426	CbGbCtD
Indinavir—ABCB1—Etoposide—prostate cancer	0.0019	0.00407	CbGbCtD
Indinavir—CYP3A4—Mitoxantrone—prostate cancer	0.0018	0.00387	CbGbCtD
Indinavir—CYP3A4—Estradiol—prostate cancer	0.00174	0.00374	CbGbCtD
Indinavir—ABCB1—Docetaxel—prostate cancer	0.00174	0.00373	CbGbCtD
Indinavir—CYP3A4—Prednisone—prostate cancer	0.0015	0.00321	CbGbCtD
Indinavir—ABCB1—Doxorubicin—prostate cancer	0.00129	0.00278	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—prostate cancer	0.00122	0.00262	CbGbCtD
Indinavir—CYP2C19—urine—prostate cancer	0.00115	0.125	CbGeAlD
Indinavir—CYP3A4—Etoposide—prostate cancer	0.00114	0.00244	CbGbCtD
Indinavir—CYP3A4—Docetaxel—prostate cancer	0.00104	0.00223	CbGbCtD
Indinavir—CYP2C9—urine—prostate cancer	0.000892	0.0968	CbGeAlD
Indinavir—CYP3A4—Doxorubicin—prostate cancer	0.000776	0.00166	CbGbCtD
Indinavir—CYP3A4—urine—prostate cancer	0.000681	0.0738	CbGeAlD
Indinavir—CYP2D6—urine—prostate cancer	0.00067	0.0727	CbGeAlD
Indinavir—ABCC2—prostate gland—prostate cancer	0.000481	0.0522	CbGeAlD
Indinavir—Nelfinavir—SLC22A1—prostate cancer	0.000444	0.181	CrCbGaD
Indinavir—SLCO1B1—renal system—prostate cancer	0.000432	0.0469	CbGeAlD
Indinavir—ABCC1—prostate gland—prostate cancer	0.000424	0.046	CbGeAlD
Indinavir—SLC22A1—renal system—prostate cancer	0.000365	0.0396	CbGeAlD
Indinavir—Nelfinavir—CYP3A5—prostate cancer	0.000358	0.146	CrCbGaD
Indinavir—ABCC1—seminal vesicle—prostate cancer	0.000358	0.0389	CbGeAlD
Indinavir—SLCO1A2—renal system—prostate cancer	0.000352	0.0382	CbGeAlD
Indinavir—ABCC2—renal system—prostate cancer	0.000328	0.0356	CbGeAlD
Indinavir—CYP3A5—prostate gland—prostate cancer	0.000326	0.0353	CbGeAlD
Indinavir—Saquinavir—SLC22A1—prostate cancer	0.000304	0.124	CrCbGaD
Indinavir—ABCC1—urethra—prostate cancer	0.000284	0.0308	CbGeAlD
Indinavir—Lopinavir—CYP2C19—prostate cancer	0.000262	0.107	CrCbGaD
Indinavir—Saquinavir—CYP3A5—prostate cancer	0.000246	0.1	CrCbGaD
Indinavir—Nelfinavir—CYP2C19—prostate cancer	0.000244	0.0994	CrCbGaD
Indinavir—SLCO1A2—testis—prostate cancer	0.000227	0.0247	CbGeAlD
Indinavir—CYP3A5—renal system—prostate cancer	0.000222	0.0241	CbGeAlD
Indinavir—ABCC2—testis—prostate cancer	0.000212	0.023	CbGeAlD
Indinavir—ABCC1—testis—prostate cancer	0.000187	0.0202	CbGeAlD
Indinavir—ABCB1—prostate gland—prostate cancer	0.000173	0.0188	CbGeAlD
Indinavir—Saquinavir—CYP2C19—prostate cancer	0.000167	0.0681	CrCbGaD
Indinavir—Lopinavir—CYP3A4—prostate cancer	0.000167	0.068	CrCbGaD
Indinavir—CYP3A4—renal system—prostate cancer	0.000167	0.0181	CbGeAlD
Indinavir—CYP2D6—renal system—prostate cancer	0.000164	0.0178	CbGeAlD
Indinavir—Nelfinavir—CYP3A4—prostate cancer	0.000155	0.0632	CrCbGaD
Indinavir—ABCC2—lymph node—prostate cancer	0.000154	0.0167	CbGeAlD
Indinavir—ABCB1—seminal vesicle—prostate cancer	0.000146	0.0159	CbGeAlD
Indinavir—ABCC1—lymph node—prostate cancer	0.000135	0.0147	CbGeAlD
Indinavir—ABCB1—epithelium—prostate cancer	0.000127	0.0138	CbGeAlD
Indinavir—ABCB1—renal system—prostate cancer	0.000118	0.0128	CbGeAlD
Indinavir—ABCB1—urethra—prostate cancer	0.000116	0.0126	CbGeAlD
Indinavir—Saquinavir—CYP3A4—prostate cancer	0.000106	0.0433	CrCbGaD
Indinavir—CYP2D6—testis—prostate cancer	0.000106	0.0115	CbGeAlD
Indinavir—ABCB1—bone marrow—prostate cancer	8.91e-05	0.00967	CbGeAlD
Indinavir—ABCB1—testis—prostate cancer	7.62e-05	0.00827	CbGeAlD
Indinavir—ABCB1—lymph node—prostate cancer	5.52e-05	0.00599	CbGeAlD
Indinavir—Hepatitis—Epirubicin—prostate cancer	2.88e-05	0.00023	CcSEcCtD
Indinavir—Thrombocytopenia—Capecitabine—prostate cancer	2.87e-05	0.00023	CcSEcCtD
Indinavir—Syncope—Prednisone—prostate cancer	2.87e-05	0.00023	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—prostate cancer	2.86e-05	0.000229	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—prostate cancer	2.86e-05	0.000228	CcSEcCtD
Indinavir—Skin disorder—Capecitabine—prostate cancer	2.85e-05	0.000228	CcSEcCtD
Indinavir—Sweating—Doxorubicin—prostate cancer	2.84e-05	0.000227	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—prostate cancer	2.84e-05	0.000227	CcSEcCtD
Indinavir—Hyperhidrosis—Capecitabine—prostate cancer	2.84e-05	0.000227	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—prostate cancer	2.83e-05	0.000226	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—prostate cancer	2.83e-05	0.000226	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—prostate cancer	2.82e-05	0.000225	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—prostate cancer	2.82e-05	0.000225	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—prostate cancer	2.81e-05	0.000224	CcSEcCtD
Indinavir—Anorexia—Capecitabine—prostate cancer	2.8e-05	0.000224	CcSEcCtD
Indinavir—Nausea—Estradiol—prostate cancer	2.8e-05	0.000223	CcSEcCtD
Indinavir—Vomiting—Mitoxantrone—prostate cancer	2.79e-05	0.000223	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—prostate cancer	2.78e-05	0.000222	CcSEcCtD
Indinavir—Rash—Mitoxantrone—prostate cancer	2.77e-05	0.000221	CcSEcCtD
Indinavir—Dermatitis—Mitoxantrone—prostate cancer	2.76e-05	0.000221	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.76e-05	0.000221	CcSEcCtD
Indinavir—Headache—Mitoxantrone—prostate cancer	2.75e-05	0.00022	CcSEcCtD
Indinavir—Insomnia—Docetaxel—prostate cancer	2.74e-05	0.000219	CcSEcCtD
Indinavir—Arthralgia—Prednisone—prostate cancer	2.73e-05	0.000218	CcSEcCtD
Indinavir—Myalgia—Prednisone—prostate cancer	2.73e-05	0.000218	CcSEcCtD
Indinavir—Paraesthesia—Docetaxel—prostate cancer	2.72e-05	0.000218	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—prostate cancer	2.72e-05	0.000217	CcSEcCtD
Indinavir—Anxiety—Prednisone—prostate cancer	2.72e-05	0.000217	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.71e-05	0.000216	CcSEcCtD
Indinavir—Dyspnoea—Docetaxel—prostate cancer	2.7e-05	0.000216	CcSEcCtD
Indinavir—Somnolence—Docetaxel—prostate cancer	2.7e-05	0.000215	CcSEcCtD
Indinavir—Discomfort—Prednisone—prostate cancer	2.7e-05	0.000215	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—prostate cancer	2.69e-05	0.000215	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—prostate cancer	2.68e-05	0.000214	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.67e-05	0.000214	CcSEcCtD
Indinavir—Flushing—Epirubicin—prostate cancer	2.67e-05	0.000213	CcSEcCtD
Indinavir—Dyspepsia—Docetaxel—prostate cancer	2.67e-05	0.000213	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—prostate cancer	2.66e-05	0.000213	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—prostate cancer	2.66e-05	0.000213	CcSEcCtD
Indinavir—Insomnia—Capecitabine—prostate cancer	2.66e-05	0.000212	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—prostate cancer	2.65e-05	0.000212	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—prostate cancer	2.64e-05	0.000211	CcSEcCtD
Indinavir—Paraesthesia—Capecitabine—prostate cancer	2.64e-05	0.000211	CcSEcCtD
Indinavir—Decreased appetite—Docetaxel—prostate cancer	2.64e-05	0.000211	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—prostate cancer	2.63e-05	0.00021	CcSEcCtD
Indinavir—Gastrointestinal disorder—Docetaxel—prostate cancer	2.62e-05	0.000209	CcSEcCtD
Indinavir—Asthenia—Etoposide—prostate cancer	2.62e-05	0.000209	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—prostate cancer	2.62e-05	0.000209	CcSEcCtD
Indinavir—Dyspnoea—Capecitabine—prostate cancer	2.62e-05	0.000209	CcSEcCtD
Indinavir—Oedema—Prednisone—prostate cancer	2.61e-05	0.000209	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—prostate cancer	2.61e-05	0.000209	CcSEcCtD
Indinavir—Fatigue—Docetaxel—prostate cancer	2.61e-05	0.000209	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—prostate cancer	2.61e-05	0.000209	CcSEcCtD
Indinavir—Nausea—Mitoxantrone—prostate cancer	2.61e-05	0.000208	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—prostate cancer	2.6e-05	0.000208	CcSEcCtD
Indinavir—Pain—Docetaxel—prostate cancer	2.59e-05	0.000207	CcSEcCtD
Indinavir—Constipation—Docetaxel—prostate cancer	2.59e-05	0.000207	CcSEcCtD
Indinavir—Dyspepsia—Capecitabine—prostate cancer	2.58e-05	0.000206	CcSEcCtD
Indinavir—Chills—Epirubicin—prostate cancer	2.58e-05	0.000206	CcSEcCtD
Indinavir—Pruritus—Etoposide—prostate cancer	2.58e-05	0.000206	CcSEcCtD
Indinavir—Shock—Prednisone—prostate cancer	2.57e-05	0.000206	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—prostate cancer	2.56e-05	0.000205	CcSEcCtD
Indinavir—Decreased appetite—Capecitabine—prostate cancer	2.55e-05	0.000204	CcSEcCtD
Indinavir—Alopecia—Epirubicin—prostate cancer	2.54e-05	0.000203	CcSEcCtD
Indinavir—Skin disorder—Prednisone—prostate cancer	2.54e-05	0.000203	CcSEcCtD
Indinavir—Gastrointestinal disorder—Capecitabine—prostate cancer	2.53e-05	0.000203	CcSEcCtD
Indinavir—Fatigue—Capecitabine—prostate cancer	2.53e-05	0.000202	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—prostate cancer	2.53e-05	0.000202	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—prostate cancer	2.52e-05	0.000201	CcSEcCtD
Indinavir—Pain—Capecitabine—prostate cancer	2.51e-05	0.000201	CcSEcCtD
Indinavir—Constipation—Capecitabine—prostate cancer	2.51e-05	0.000201	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—prostate cancer	2.51e-05	0.0002	CcSEcCtD
Indinavir—Feeling abnormal—Docetaxel—prostate cancer	2.5e-05	0.0002	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—prostate cancer	2.5e-05	0.000199	CcSEcCtD
Indinavir—Anorexia—Prednisone—prostate cancer	2.49e-05	0.000199	CcSEcCtD
Indinavir—Gastrointestinal pain—Docetaxel—prostate cancer	2.48e-05	0.000198	CcSEcCtD
Indinavir—Flushing—Doxorubicin—prostate cancer	2.47e-05	0.000198	CcSEcCtD
Indinavir—Flatulence—Epirubicin—prostate cancer	2.47e-05	0.000197	CcSEcCtD
Indinavir—Tension—Epirubicin—prostate cancer	2.46e-05	0.000196	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—prostate cancer	2.45e-05	0.000196	CcSEcCtD
Indinavir—Nervousness—Epirubicin—prostate cancer	2.43e-05	0.000194	CcSEcCtD
Indinavir—Back pain—Epirubicin—prostate cancer	2.42e-05	0.000194	CcSEcCtD
Indinavir—Feeling abnormal—Capecitabine—prostate cancer	2.42e-05	0.000193	CcSEcCtD
Indinavir—Dizziness—Etoposide—prostate cancer	2.41e-05	0.000193	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—prostate cancer	2.41e-05	0.000193	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—prostate cancer	2.41e-05	0.000192	CcSEcCtD
Indinavir—Gastrointestinal pain—Capecitabine—prostate cancer	2.4e-05	0.000192	CcSEcCtD
Indinavir—Abdominal pain—Docetaxel—prostate cancer	2.4e-05	0.000192	CcSEcCtD
Indinavir—Body temperature increased—Docetaxel—prostate cancer	2.4e-05	0.000192	CcSEcCtD
Indinavir—Chills—Doxorubicin—prostate cancer	2.39e-05	0.000191	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—prostate cancer	2.38e-05	0.00019	CcSEcCtD
Indinavir—Insomnia—Prednisone—prostate cancer	2.37e-05	0.000189	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—prostate cancer	2.36e-05	0.000189	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—prostate cancer	2.35e-05	0.000188	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—prostate cancer	2.35e-05	0.000188	CcSEcCtD
Indinavir—Urticaria—Capecitabine—prostate cancer	2.33e-05	0.000186	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—prostate cancer	2.33e-05	0.000186	CcSEcCtD
Indinavir—Abdominal pain—Capecitabine—prostate cancer	2.32e-05	0.000185	CcSEcCtD
Indinavir—Body temperature increased—Capecitabine—prostate cancer	2.32e-05	0.000185	CcSEcCtD
Indinavir—Vomiting—Etoposide—prostate cancer	2.32e-05	0.000185	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—prostate cancer	2.32e-05	0.000185	CcSEcCtD
Indinavir—Anaemia—Epirubicin—prostate cancer	2.32e-05	0.000185	CcSEcCtD
Indinavir—Agitation—Epirubicin—prostate cancer	2.3e-05	0.000184	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—prostate cancer	2.3e-05	0.000184	CcSEcCtD
Indinavir—Rash—Etoposide—prostate cancer	2.3e-05	0.000184	CcSEcCtD
Indinavir—Dermatitis—Etoposide—prostate cancer	2.3e-05	0.000184	CcSEcCtD
Indinavir—Headache—Etoposide—prostate cancer	2.29e-05	0.000183	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—prostate cancer	2.28e-05	0.000183	CcSEcCtD
Indinavir—Tension—Doxorubicin—prostate cancer	2.28e-05	0.000182	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—prostate cancer	2.27e-05	0.000182	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—prostate cancer	2.27e-05	0.000181	CcSEcCtD
Indinavir—Malaise—Epirubicin—prostate cancer	2.26e-05	0.000181	CcSEcCtD
Indinavir—Fatigue—Prednisone—prostate cancer	2.25e-05	0.00018	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—prostate cancer	2.25e-05	0.00018	CcSEcCtD
Indinavir—Vertigo—Epirubicin—prostate cancer	2.25e-05	0.00018	CcSEcCtD
Indinavir—Syncope—Epirubicin—prostate cancer	2.25e-05	0.00018	CcSEcCtD
Indinavir—Back pain—Doxorubicin—prostate cancer	2.24e-05	0.000179	CcSEcCtD
Indinavir—Constipation—Prednisone—prostate cancer	2.24e-05	0.000179	CcSEcCtD
Indinavir—Hypersensitivity—Docetaxel—prostate cancer	2.23e-05	0.000179	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—prostate cancer	2.23e-05	0.000178	CcSEcCtD
Indinavir—Palpitations—Epirubicin—prostate cancer	2.21e-05	0.000177	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—prostate cancer	2.2e-05	0.000176	CcSEcCtD
Indinavir—Cough—Epirubicin—prostate cancer	2.19e-05	0.000175	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—prostate cancer	2.19e-05	0.000175	CcSEcCtD
Indinavir—Asthenia—Docetaxel—prostate cancer	2.18e-05	0.000174	CcSEcCtD
Indinavir—Nausea—Etoposide—prostate cancer	2.17e-05	0.000173	CcSEcCtD
Indinavir—Hypersensitivity—Capecitabine—prostate cancer	2.16e-05	0.000173	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—prostate cancer	2.15e-05	0.000172	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—prostate cancer	2.15e-05	0.000172	CcSEcCtD
Indinavir—Pruritus—Docetaxel—prostate cancer	2.15e-05	0.000171	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—prostate cancer	2.14e-05	0.000171	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—prostate cancer	2.14e-05	0.000171	CcSEcCtD
Indinavir—Chest pain—Epirubicin—prostate cancer	2.13e-05	0.00017	CcSEcCtD
Indinavir—Myalgia—Epirubicin—prostate cancer	2.13e-05	0.00017	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—prostate cancer	2.13e-05	0.00017	CcSEcCtD
Indinavir—Agitation—Doxorubicin—prostate cancer	2.13e-05	0.00017	CcSEcCtD
Indinavir—Anxiety—Epirubicin—prostate cancer	2.13e-05	0.00017	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.12e-05	0.000169	CcSEcCtD
Indinavir—Discomfort—Epirubicin—prostate cancer	2.11e-05	0.000168	CcSEcCtD
Indinavir—Asthenia—Capecitabine—prostate cancer	2.11e-05	0.000168	CcSEcCtD
Indinavir—Malaise—Doxorubicin—prostate cancer	2.09e-05	0.000167	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—prostate cancer	2.09e-05	0.000167	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—prostate cancer	2.08e-05	0.000166	CcSEcCtD
Indinavir—Syncope—Doxorubicin—prostate cancer	2.08e-05	0.000166	CcSEcCtD
Indinavir—Urticaria—Prednisone—prostate cancer	2.08e-05	0.000166	CcSEcCtD
Indinavir—Pruritus—Capecitabine—prostate cancer	2.08e-05	0.000166	CcSEcCtD
Indinavir—Diarrhoea—Docetaxel—prostate cancer	2.07e-05	0.000166	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—prostate cancer	2.07e-05	0.000165	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—prostate cancer	2.07e-05	0.000165	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—prostate cancer	2.05e-05	0.000164	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—prostate cancer	2.05e-05	0.000163	CcSEcCtD
Indinavir—Oedema—Epirubicin—prostate cancer	2.05e-05	0.000163	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—prostate cancer	2.04e-05	0.000163	CcSEcCtD
Indinavir—Cough—Doxorubicin—prostate cancer	2.02e-05	0.000162	CcSEcCtD
Indinavir—Shock—Epirubicin—prostate cancer	2.01e-05	0.000161	CcSEcCtD
Indinavir—Diarrhoea—Capecitabine—prostate cancer	2.01e-05	0.00016	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—prostate cancer	2.01e-05	0.00016	CcSEcCtD
Indinavir—Dizziness—Docetaxel—prostate cancer	2.01e-05	0.00016	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—prostate cancer	2e-05	0.00016	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—prostate cancer	1.99e-05	0.000159	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—prostate cancer	1.98e-05	0.000158	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—prostate cancer	1.97e-05	0.000158	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—prostate cancer	1.97e-05	0.000158	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—prostate cancer	1.97e-05	0.000158	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—prostate cancer	1.97e-05	0.000157	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.96e-05	0.000157	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—prostate cancer	1.95e-05	0.000156	CcSEcCtD
Indinavir—Anorexia—Epirubicin—prostate cancer	1.95e-05	0.000156	CcSEcCtD
Indinavir—Dizziness—Capecitabine—prostate cancer	1.94e-05	0.000155	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—prostate cancer	1.93e-05	0.000154	CcSEcCtD
Indinavir—Vomiting—Docetaxel—prostate cancer	1.93e-05	0.000154	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—prostate cancer	1.93e-05	0.000154	CcSEcCtD
Indinavir—Rash—Docetaxel—prostate cancer	1.91e-05	0.000153	CcSEcCtD
Indinavir—Dermatitis—Docetaxel—prostate cancer	1.91e-05	0.000153	CcSEcCtD
Indinavir—Headache—Docetaxel—prostate cancer	1.9e-05	0.000152	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—prostate cancer	1.89e-05	0.000151	CcSEcCtD
Indinavir—Oedema—Doxorubicin—prostate cancer	1.89e-05	0.000151	CcSEcCtD
Indinavir—Asthenia—Prednisone—prostate cancer	1.88e-05	0.00015	CcSEcCtD
Indinavir—Vomiting—Capecitabine—prostate cancer	1.87e-05	0.000149	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.86e-05	0.000149	CcSEcCtD
Indinavir—Shock—Doxorubicin—prostate cancer	1.86e-05	0.000149	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—prostate cancer	1.86e-05	0.000148	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—prostate cancer	1.85e-05	0.000148	CcSEcCtD
Indinavir—Rash—Capecitabine—prostate cancer	1.85e-05	0.000148	CcSEcCtD
Indinavir—Pruritus—Prednisone—prostate cancer	1.85e-05	0.000148	CcSEcCtD
Indinavir—Insomnia—Epirubicin—prostate cancer	1.85e-05	0.000148	CcSEcCtD
Indinavir—Dermatitis—Capecitabine—prostate cancer	1.85e-05	0.000148	CcSEcCtD
Indinavir—Headache—Capecitabine—prostate cancer	1.84e-05	0.000147	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—prostate cancer	1.84e-05	0.000147	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—prostate cancer	1.84e-05	0.000147	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—prostate cancer	1.83e-05	0.000146	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—prostate cancer	1.82e-05	0.000146	CcSEcCtD
Indinavir—Somnolence—Epirubicin—prostate cancer	1.82e-05	0.000145	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—prostate cancer	1.8e-05	0.000144	CcSEcCtD
Indinavir—Nausea—Docetaxel—prostate cancer	1.8e-05	0.000144	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—prostate cancer	1.8e-05	0.000144	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—prostate cancer	1.79e-05	0.000143	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—prostate cancer	1.78e-05	0.000142	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—prostate cancer	1.77e-05	0.000141	CcSEcCtD
Indinavir—Fatigue—Epirubicin—prostate cancer	1.76e-05	0.000141	CcSEcCtD
Indinavir—Constipation—Epirubicin—prostate cancer	1.75e-05	0.00014	CcSEcCtD
Indinavir—Pain—Epirubicin—prostate cancer	1.75e-05	0.00014	CcSEcCtD
Indinavir—Nausea—Capecitabine—prostate cancer	1.74e-05	0.000139	CcSEcCtD
Indinavir—Dizziness—Prednisone—prostate cancer	1.73e-05	0.000138	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.72e-05	0.000138	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—prostate cancer	1.71e-05	0.000137	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—prostate cancer	1.7e-05	0.000136	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—prostate cancer	1.69e-05	0.000135	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—prostate cancer	1.69e-05	0.000135	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—prostate cancer	1.68e-05	0.000134	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—prostate cancer	1.67e-05	0.000134	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—prostate cancer	1.67e-05	0.000133	CcSEcCtD
Indinavir—Vomiting—Prednisone—prostate cancer	1.66e-05	0.000133	CcSEcCtD
Indinavir—Rash—Prednisone—prostate cancer	1.65e-05	0.000132	CcSEcCtD
Indinavir—Dermatitis—Prednisone—prostate cancer	1.65e-05	0.000132	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—prostate cancer	1.64e-05	0.000131	CcSEcCtD
Indinavir—Headache—Prednisone—prostate cancer	1.64e-05	0.000131	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.63e-05	0.000131	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—prostate cancer	1.63e-05	0.00013	CcSEcCtD
Indinavir—Urticaria—Epirubicin—prostate cancer	1.62e-05	0.00013	CcSEcCtD
Indinavir—Pain—Doxorubicin—prostate cancer	1.62e-05	0.000129	CcSEcCtD
Indinavir—Constipation—Doxorubicin—prostate cancer	1.62e-05	0.000129	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—prostate cancer	1.62e-05	0.000129	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—prostate cancer	1.62e-05	0.000129	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—prostate cancer	1.56e-05	0.000125	CcSEcCtD
Indinavir—Nausea—Prednisone—prostate cancer	1.55e-05	0.000124	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—prostate cancer	1.55e-05	0.000124	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—prostate cancer	1.51e-05	0.00012	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—prostate cancer	1.5e-05	0.00012	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—prostate cancer	1.5e-05	0.00012	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—prostate cancer	1.5e-05	0.00012	CcSEcCtD
Indinavir—Asthenia—Epirubicin—prostate cancer	1.47e-05	0.000117	CcSEcCtD
Indinavir—Pruritus—Epirubicin—prostate cancer	1.45e-05	0.000116	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—prostate cancer	1.4e-05	0.000112	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—prostate cancer	1.39e-05	0.000111	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—prostate cancer	1.36e-05	0.000108	CcSEcCtD
Indinavir—Dizziness—Epirubicin—prostate cancer	1.35e-05	0.000108	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—prostate cancer	1.34e-05	0.000107	CcSEcCtD
Indinavir—Vomiting—Epirubicin—prostate cancer	1.3e-05	0.000104	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—prostate cancer	1.29e-05	0.000103	CcSEcCtD
Indinavir—Rash—Epirubicin—prostate cancer	1.29e-05	0.000103	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—prostate cancer	1.29e-05	0.000103	CcSEcCtD
Indinavir—Headache—Epirubicin—prostate cancer	1.28e-05	0.000102	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—prostate cancer	1.25e-05	0.0001	CcSEcCtD
Indinavir—Nausea—Epirubicin—prostate cancer	1.21e-05	9.71e-05	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—prostate cancer	1.2e-05	9.61e-05	CcSEcCtD
Indinavir—Rash—Doxorubicin—prostate cancer	1.19e-05	9.53e-05	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—prostate cancer	1.19e-05	9.52e-05	CcSEcCtD
Indinavir—Headache—Doxorubicin—prostate cancer	1.19e-05	9.47e-05	CcSEcCtD
Indinavir—Nausea—Doxorubicin—prostate cancer	1.12e-05	8.98e-05	CcSEcCtD
Indinavir—CYP3A4—Metabolism—ABCG5—prostate cancer	2.21e-06	3.07e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.21e-06	3.07e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—INS—prostate cancer	2.2e-06	3.06e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TH—prostate cancer	2.2e-06	3.06e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.19e-06	3.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.18e-06	3.02e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP3A4—prostate cancer	2.18e-06	3.02e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—prostate cancer	2.17e-06	3.01e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CTNNB1—prostate cancer	2.17e-06	3.01e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CREBBP—prostate cancer	2.16e-06	3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.16e-06	3e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA1—prostate cancer	2.16e-06	3e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.15e-06	2.98e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1B1—prostate cancer	2.14e-06	2.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.13e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTO1—prostate cancer	2.13e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAT2—prostate cancer	2.13e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ERCC2—prostate cancer	2.13e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.13e-06	2.95e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GGT1—prostate cancer	2.12e-06	2.95e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—prostate cancer	2.12e-06	2.94e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—prostate cancer	2.11e-06	2.93e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.11e-06	2.93e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NOS3—prostate cancer	2.11e-06	2.93e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NQO1—prostate cancer	2.1e-06	2.92e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NCOA1—prostate cancer	2.09e-06	2.9e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NQO1—prostate cancer	2.09e-06	2.9e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TH—prostate cancer	2.07e-06	2.88e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GGT1—prostate cancer	2.07e-06	2.88e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.06e-06	2.86e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TH—prostate cancer	2.05e-06	2.85e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—INS—prostate cancer	2.05e-06	2.85e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.05e-06	2.85e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.05e-06	2.84e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—prostate cancer	2.05e-06	2.84e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLCB2—prostate cancer	2.05e-06	2.84e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.05e-06	2.84e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LRP2—prostate cancer	2.05e-06	2.84e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.04e-06	2.84e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NCOA1—prostate cancer	2.04e-06	2.84e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.03e-06	2.82e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—prostate cancer	2.03e-06	2.82e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.02e-06	2.81e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.02e-06	2.8e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EP300—prostate cancer	2.01e-06	2.8e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP19A1—prostate cancer	2.01e-06	2.79e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CREBBP—prostate cancer	2.01e-06	2.79e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—P4HB—prostate cancer	2.01e-06	2.79e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—prostate cancer	2e-06	2.78e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1B1—prostate cancer	2e-06	2.78e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—RXRA—prostate cancer	1.99e-06	2.76e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARA—prostate cancer	1.97e-06	2.73e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—prostate cancer	1.96e-06	2.73e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—prostate cancer	1.96e-06	2.72e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GGT1—prostate cancer	1.95e-06	2.71e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.95e-06	2.71e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—prostate cancer	1.94e-06	2.7e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—RXRA—prostate cancer	1.94e-06	2.7e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GGT1—prostate cancer	1.94e-06	2.69e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.93e-06	2.69e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NOS3—prostate cancer	1.93e-06	2.68e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—prostate cancer	1.93e-06	2.68e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NCOA1—prostate cancer	1.92e-06	2.67e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—COMT—prostate cancer	1.92e-06	2.66e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—prostate cancer	1.91e-06	2.65e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NCOA1—prostate cancer	1.91e-06	2.65e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—prostate cancer	1.91e-06	2.65e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.9e-06	2.64e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.9e-06	2.63e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—prostate cancer	1.89e-06	2.62e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.88e-06	2.61e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ITPR1—prostate cancer	1.88e-06	2.61e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—EP300—prostate cancer	1.87e-06	2.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MED12—prostate cancer	1.87e-06	2.6e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—COMT—prostate cancer	1.87e-06	2.6e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—prostate cancer	1.86e-06	2.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GNG5—prostate cancer	1.86e-06	2.58e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAV1—prostate cancer	1.85e-06	2.57e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.85e-06	2.56e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ITPR1—prostate cancer	1.83e-06	2.54e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—RXRA—prostate cancer	1.83e-06	2.54e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—RXRA—prostate cancer	1.81e-06	2.52e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NOS3—prostate cancer	1.8e-06	2.5e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOA3—prostate cancer	1.79e-06	2.48e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.78e-06	2.48e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TYMS—prostate cancer	1.77e-06	2.46e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—prostate cancer	1.77e-06	2.46e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—prostate cancer	1.77e-06	2.46e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.76e-06	2.45e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—COMT—prostate cancer	1.76e-06	2.45e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—prostate cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—prostate cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—prostate cancer	1.75e-06	2.43e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—prostate cancer	1.75e-06	2.43e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—COMT—prostate cancer	1.75e-06	2.43e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—prostate cancer	1.74e-06	2.42e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TYMS—prostate cancer	1.73e-06	2.4e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ITPR1—prostate cancer	1.73e-06	2.4e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—LPL—prostate cancer	1.72e-06	2.39e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—prostate cancer	1.72e-06	2.38e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ITPR1—prostate cancer	1.71e-06	2.38e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—prostate cancer	1.71e-06	2.38e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HPGDS—prostate cancer	1.71e-06	2.37e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.7e-06	2.35e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—EP300—prostate cancer	1.69e-06	2.34e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.68e-06	2.34e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.68e-06	2.34e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—prostate cancer	1.68e-06	2.33e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—LPL—prostate cancer	1.68e-06	2.33e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.66e-06	2.31e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.66e-06	2.31e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ACHE—prostate cancer	1.65e-06	2.3e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—prostate cancer	1.65e-06	2.3e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ERCC2—prostate cancer	1.65e-06	2.29e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—prostate cancer	1.65e-06	2.29e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.64e-06	2.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TYMS—prostate cancer	1.63e-06	2.27e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A1—prostate cancer	1.62e-06	2.25e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—prostate cancer	1.62e-06	2.25e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TYMS—prostate cancer	1.62e-06	2.25e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—prostate cancer	1.61e-06	2.24e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ERCC2—prostate cancer	1.61e-06	2.23e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—EP300—prostate cancer	1.6e-06	2.23e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—prostate cancer	1.6e-06	2.22e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—INS—prostate cancer	1.59e-06	2.21e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.59e-06	2.21e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PRKACB—prostate cancer	1.58e-06	2.2e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—LPL—prostate cancer	1.58e-06	2.2e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—LPL—prostate cancer	1.57e-06	2.18e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.57e-06	2.18e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CREBBP—prostate cancer	1.56e-06	2.17e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—prostate cancer	1.55e-06	2.15e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—prostate cancer	1.54e-06	2.14e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.53e-06	2.12e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARA—prostate cancer	1.52e-06	2.11e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ERCC2—prostate cancer	1.52e-06	2.11e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.51e-06	2.1e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—prostate cancer	1.51e-06	2.1e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ERCC2—prostate cancer	1.5e-06	2.09e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOA2—prostate cancer	1.49e-06	2.07e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—prostate cancer	1.49e-06	2.07e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARA—prostate cancer	1.48e-06	2.06e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.48e-06	2.06e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—EP300—prostate cancer	1.47e-06	2.04e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—prostate cancer	1.43e-06	1.99e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAV1—prostate cancer	1.43e-06	1.98e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—prostate cancer	1.42e-06	1.98e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.42e-06	1.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—prostate cancer	1.41e-06	1.96e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARA—prostate cancer	1.4e-06	1.94e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NOS3—prostate cancer	1.4e-06	1.94e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAV1—prostate cancer	1.39e-06	1.94e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.39e-06	1.93e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.93e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARA—prostate cancer	1.39e-06	1.92e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NQO1—prostate cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—EP300—prostate cancer	1.37e-06	1.9e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.36e-06	1.9e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TH—prostate cancer	1.36e-06	1.88e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—prostate cancer	1.32e-06	1.83e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.32e-06	1.83e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAV1—prostate cancer	1.31e-06	1.83e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAV1—prostate cancer	1.3e-06	1.81e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.3e-06	1.81e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.29e-06	1.79e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—prostate cancer	1.28e-06	1.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GGT1—prostate cancer	1.28e-06	1.77e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—prostate cancer	1.27e-06	1.76e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOA1—prostate cancer	1.26e-06	1.75e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—prostate cancer	1.25e-06	1.73e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.24e-06	1.73e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.24e-06	1.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—INS—prostate cancer	1.23e-06	1.71e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—prostate cancer	1.22e-06	1.69e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CREBBP—prostate cancer	1.21e-06	1.68e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—INS—prostate cancer	1.2e-06	1.67e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.66e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RXRA—prostate cancer	1.2e-06	1.66e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.19e-06	1.65e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.65e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CREBBP—prostate cancer	1.18e-06	1.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—COMT—prostate cancer	1.15e-06	1.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—prostate cancer	1.15e-06	1.59e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.14e-06	1.59e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—INS—prostate cancer	1.13e-06	1.57e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—prostate cancer	1.13e-06	1.57e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ITPR1—prostate cancer	1.13e-06	1.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—INS—prostate cancer	1.12e-06	1.56e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—prostate cancer	1.12e-06	1.55e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—prostate cancer	1.11e-06	1.55e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CREBBP—prostate cancer	1.11e-06	1.54e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CREBBP—prostate cancer	1.1e-06	1.53e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.09e-06	1.51e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NOS3—prostate cancer	1.08e-06	1.5e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TYMS—prostate cancer	1.07e-06	1.48e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—EP300—prostate cancer	1.06e-06	1.48e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NOS3—prostate cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—prostate cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.04e-06	1.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LPL—prostate cancer	1.03e-06	1.44e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—prostate cancer	1.02e-06	1.42e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.01e-06	1.41e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.99e-07	1.39e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.97e-07	1.39e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NOS3—prostate cancer	9.94e-07	1.38e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ERCC2—prostate cancer	9.91e-07	1.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—prostate cancer	9.88e-07	1.37e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NOS3—prostate cancer	9.85e-07	1.37e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—prostate cancer	9.73e-07	1.35e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—prostate cancer	9.68e-07	1.34e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—prostate cancer	9.64e-07	1.34e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—prostate cancer	9.31e-07	1.29e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.17e-07	1.27e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARA—prostate cancer	9.14e-07	1.27e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—prostate cancer	9.09e-07	1.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—prostate cancer	9.09e-07	1.26e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—prostate cancer	9.01e-07	1.25e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—prostate cancer	8.89e-07	1.23e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—prostate cancer	8.62e-07	1.2e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAV1—prostate cancer	8.59e-07	1.19e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—prostate cancer	8.41e-07	1.17e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—prostate cancer	8.27e-07	1.15e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—EP300—prostate cancer	8.22e-07	1.14e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—EP300—prostate cancer	8.02e-07	1.11e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—prostate cancer	7.93e-07	1.1e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—prostate cancer	7.86e-07	1.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—prostate cancer	7.86e-07	1.09e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.83e-07	1.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—EP300—prostate cancer	7.56e-07	1.05e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—EP300—prostate cancer	7.49e-07	1.04e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—INS—prostate cancer	7.41e-07	1.03e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CREBBP—prostate cancer	7.26e-07	1.01e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.88e-07	9.56e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NOS3—prostate cancer	6.5e-07	9.02e-06	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—prostate cancer	6.42e-07	8.92e-06	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—prostate cancer	6.08e-07	8.44e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—prostate cancer	6e-07	8.33e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—prostate cancer	5.94e-07	8.25e-06	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—prostate cancer	5.93e-07	8.24e-06	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.59e-07	7.77e-06	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.54e-07	7.7e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—prostate cancer	5.18e-07	7.2e-06	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—prostate cancer	4.97e-07	6.9e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—EP300—prostate cancer	4.94e-07	6.86e-06	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—prostate cancer	4.85e-07	6.73e-06	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—prostate cancer	4.57e-07	6.34e-06	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—prostate cancer	4.53e-07	6.29e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.66e-07	5.08e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—prostate cancer	2.99e-07	4.15e-06	CbGpPWpGaD
